Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to $1.8 million.

  • Strata Critical Medical's Change in Receivables rose 15286.05% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 7033.85%. This contributed to the annual value of $998000.0 for FY2024, which is 9026.72% down from last year.
  • As of Q3 2025, Strata Critical Medical's Change in Receivables stood at $1.8 million, which was up 15286.05% from $6.3 million recorded in Q2 2025.
  • Strata Critical Medical's Change in Receivables' 5-year high stood at $6.3 million during Q2 2025, with a 5-year trough of -$3.4 million in Q3 2024.
  • In the last 5 years, Strata Critical Medical's Change in Receivables had a median value of $703000.0 in 2022 and averaged $1.5 million.
  • In the last 5 years, Strata Critical Medical's Change in Receivables soared by 236946.11% in 2022 and then tumbled by 199040.0% in 2024.
  • Over the past 5 years, Strata Critical Medical's Change in Receivables (Quarter) stood at $1.8 million in 2021, then crashed by 50.31% to $886000.0 in 2022, then crashed by 114.11% to -$125000.0 in 2023, then plummeted by 1990.4% to -$2.6 million in 2024, then soared by 167.89% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $6.3 million for Q2 2025, and $520000.0 during Q1 2025.